333 related articles for article (PubMed ID: 16859525)
21. [Progress of research in osteoarthritis. Metalloproteinases in osteoarthritis].
Okada A; Okada Y
Clin Calcium; 2009 Nov; 19(11):1593-601. PubMed ID: 19880991
[TBL] [Abstract][Full Text] [Related]
22. Detection of gene expression in synovium of patients with osteoarthritis using a random sequencing method.
Okabe T; Ohmori Y; Tanigami A; Hishigaki H; Suzuki Y; Sugano S; Kawaguchi A; Nakaya H; Wakitani S
Acta Orthop; 2007 Oct; 78(5):687-92. PubMed ID: 17966030
[TBL] [Abstract][Full Text] [Related]
23. Inflammation and Degeneration in Cartilage Samples from Patients with Femoroacetabular Impingement.
Chinzei N; Hashimoto S; Fujishiro T; Hayashi S; Kanzaki N; Uchida S; Kuroda R; Kurosaka M
J Bone Joint Surg Am; 2016 Jan; 98(2):135-41. PubMed ID: 26791034
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of cystatin C in synovium does not reduce synovitis or cartilage degradation in established osteoarthritis.
Kyostio-Moore S; Piraino S; Berthelette P; Moran N; Serriello J; Bendele A; Sookdeo C; Nambiar B; Ewing P; Armentano D; Matthews GL
Arthritis Res Ther; 2015 Jan; 17(1):5. PubMed ID: 25592743
[TBL] [Abstract][Full Text] [Related]
25. Apelin plays a catabolic role on articular cartilage: in vivo and in vitro studies.
Hu PF; Chen WP; Tang JL; Bao JP; Wu LD
Int J Mol Med; 2010 Sep; 26(3):357-63. PubMed ID: 20664951
[TBL] [Abstract][Full Text] [Related]
26. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
27. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
28. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
[TBL] [Abstract][Full Text] [Related]
29. Analysis of fracture healing by large-scale transcriptional profile identified temporal relationships between metalloproteinase and ADAMTS mRNA expression.
Wang K; Vishwanath P; Eichler GS; Al-Sebaei MO; Edgar CM; Einhorn TA; Smith TF; Gerstenfeld LC
Matrix Biol; 2006 Jul; 25(5):271-81. PubMed ID: 16584876
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the inflammatory response in experimentally induced synovitis in the horse: a comparison of recombinant equine interleukin 1 beta and lipopolysaccharide.
Ross TN; Kisiday JD; Hess T; McIlwraith CW
Osteoarthritis Cartilage; 2012 Dec; 20(12):1583-90. PubMed ID: 22917743
[TBL] [Abstract][Full Text] [Related]
31. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis.
Bondeson J; Wainwright SD; Lauder S; Amos N; Hughes CE
Arthritis Res Ther; 2006; 8(6):R187. PubMed ID: 17177994
[TBL] [Abstract][Full Text] [Related]
32. Healthy and Osteoarthritic Synovial Fibroblasts Produce a Disintegrin and Metalloproteinase with Thrombospondin Motifs 4, 5, 7, and 12: Induction by IL-1β and Fibronectin and Contribution to Cartilage Damage.
Pérez-García S; Gutiérrez-Cañas I; Seoane IV; Fernández J; Mellado M; Leceta J; Tío L; Villanueva-Romero R; Juarranz Y; Gomariz RP
Am J Pathol; 2016 Sep; 186(9):2449-61. PubMed ID: 27449198
[TBL] [Abstract][Full Text] [Related]
33. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis.
Ishiguro N; Ito T; Ito H; Iwata H; Jugessur H; Ionescu M; Poole AR
Arthritis Rheum; 1999 Jan; 42(1):129-36. PubMed ID: 9920023
[TBL] [Abstract][Full Text] [Related]
34. Matrix-degrading metalloproteinases and their roles in joint destruction.
Okada Y
Mod Rheumatol; 2000 Sep; 10(3):121-8. PubMed ID: 24383588
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinase 17 is necessary for cartilage aggrecan degradation in an inflammatory environment.
Clements KM; Flannelly JK; Tart J; Brockbank SM; Wardale J; Freeth J; Parker AE; Newham P
Ann Rheum Dis; 2011 Apr; 70(4):683-9. PubMed ID: 21216815
[TBL] [Abstract][Full Text] [Related]
36. Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis.
Pelletier JP; Mineau F; Faure MP; Martel-Pelletier J
Arthritis Rheum; 1990 Oct; 33(10):1466-76. PubMed ID: 2171538
[TBL] [Abstract][Full Text] [Related]
37. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.
Stokes A; Joutsa J; Ala-Aho R; Pitchers M; Pennington CJ; Martin C; Premachandra DJ; Okada Y; Peltonen J; Grénman R; James HA; Edwards DR; Kähäri VM
Clin Cancer Res; 2010 Apr; 16(7):2022-35. PubMed ID: 20305301
[TBL] [Abstract][Full Text] [Related]
38. Altered proteolytic activity and expression of MMPs and aggrecanases and their inhibitors in Kashin-Beck disease.
Chen J; Luo M; Wang W; Zhang Z; He Y; Duance VC; Hughes CE; Caterson B; Cao J
J Orthop Res; 2015 Jan; 33(1):47-55. PubMed ID: 25263345
[TBL] [Abstract][Full Text] [Related]
39. [Destruction of articular cartilage].
Koike T
Clin Calcium; 2006 Sep; 16(9):1543-47. PubMed ID: 16951481
[TBL] [Abstract][Full Text] [Related]
40. Dual regulation of metalloproteinase expression in chondrocytes by Wnt-1-inducible signaling pathway protein 3/CCN6.
Baker N; Sharpe P; Culley K; Otero M; Bevan D; Newham P; Barker W; Clements KM; Langham CJ; Goldring MB; Gavrilović J
Arthritis Rheum; 2012 Jul; 64(7):2289-99. PubMed ID: 22294415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
